THE NEXT GENERATION OF THERAPEUTIC PROTEINS Trademark Information

GlycoFi, Inc.

Custom manufacture of protein, glycoprotein, antibodies through glycosylation, protein glycosylation, genetic engineering, protein production, glycosylation engineering and fermentation to the order and/or specification of others in the field of biotechnology

Research, development and consultation services in the field of biotechnology, namely, protein production, glycoprotein production, antibody production, protein glycosylation, genetic engineering, glycosylation engineering and fermentation

This is a brand page for the THE NEXT GENERATION OF THERAPEUTIC PROTEINS trademark by GlycoFi, Inc.  in Lebanon, NH, 03766.

Write a review about a product or service associated with this THE NEXT GENERATION OF THERAPEUTIC PROTEINS trademark. Or, contact the owner GlycoFi, Inc. of the THE NEXT GENERATION OF THERAPEUTIC PROTEINS trademark by filing a request to communicate with the Legal Correspondent for licensing, use, and/or questions related to the THE NEXT GENERATION OF THERAPEUTIC PROTEINS trademark.

On Wednesday, May 19, 2004, a U.S. federal trademark registration was filed for THE NEXT GENERATION OF THERAPEUTIC PROTEINS. The USPTO has given the THE NEXT GENERATION OF THERAPEUTIC PROTEINS trademark serial number of 78421580. The current federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED. The correspondent listed for THE NEXT GENERATION OF THERAPEUTIC PROTEINS is SUSAN C. MATTSON of Merck & Co., Inc., WS3B-07, One Merck Drive, PO Box 100 Whitehouse Station NJ 08889-0100 . The THE NEXT GENERATION OF THERAPEUTIC PROTEINS trademark is filed in the category of Treatment & Processing of Materials Services , Computer & Software Services & Scientific Services . The description provided to the USPTO for THE NEXT GENERATION OF THERAPEUTIC PROTEINS is Custom manufacture of protein, glycoprotein, antibodies through glycosylation, protein glycosylation, genetic engineering, protein production, glycosylation engineering and fermentation to the order and/or specification of others in the field of biotechnology.

Word mark: THE NEXT GENERATION OF THERAPEUTIC PROTEINS
Status/Status Date:
ABANDONED - NO STATEMENT OF USE FILED
8/22/2007
Serial Number: 78421580
Filing Date: 5/19/2004
Registration Number: NOT AVAILABLE
Registration Date: NOT AVAILABLE
Goods and Services: Custom manufacture of protein, glycoprotein, antibodies through glycosylation, protein glycosylation, genetic engineering, protein production, glycosylation engineering and fermentation to the order and/or specification of others in the field of biotechnology
Mark Description: NOT AVAILABLE
Type Of Mark: Service Mark
Published For Opposition Date: 11/29/2005
Last Applicant/Owner: GlycoFi, Inc.
Lebanon, NH 03766
Mark Drawing Code: Standard Character Mark
Design Search: (NO DATA)
Register Type: Principal
Disclaimer: ("THERAPEUTIC PROTEINS")
Correspondent:
Merck & Co., Inc.
WS3B-07
One Merck Drive, PO Box 100
Whitehouse Station NJ 08889-0100

Classification Information

Intent to Use Trademark - Applicant has not submitted proof of use in commerce the the USPTO.

Primary Class: Class Details:
Class (040)
Treatment of materials.
First Use Anywhere: : Not provided
First Use In Commerce: Not provided
Class (042)
Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
First Use Anywhere: : Not provided
First Use In Commerce: Not provided

Trademarkia is the largest search engine for U.S. trademarks. Each month hundreds of trademarks around the world are filed by licensed attorneys in the Trademarkia Network Law firms! You can register your trademark in 170+ countries in the world through Trademarkia Network Law firms.

Trademarkia-Network law firms can help you incorporate a business around your THE NEXT GENERATION OF THERAPEUTIC PROTEINS trademark in less than 5 minutes. Trademarkia makes the process easy and convenient, so start now!

Trademarkia.com is a free search engine of publicly available government records. Trademarkia.com is not a law firm and does not represent owners & correspondents listed on this page.

Trademark Document Retrieval >>

100% Satisfaction Guarantee protect your valuable brand now.

  • 1. Trademarkia Network law firm - #1 U.S. Trademark Filing from 2010 to now.
  • 2. Describe how your business or product is being used. Register your mark in 176+ countries. Just $199 + govt fees! Start here >>
  • 1. Top Global Specialist - Credibility and Experience!
  • 2. All processes will be performed in a timely manner. You will be informed periodically about the process.
Current Trademark Status:
8/22/2007
ABANDONED - NO STATEMENT OF USE FILED
Correspondent Search:

SUSAN C. MATTSON is a correspondent of THE NEXT GENERATION OF THERAPEUTIC PROTEINS trademark.

Current Overall Rating:
RatingRatingRatingRatingRating (0 review)
What You Can Do:
Trademarkia lets you see how your personal name, product name, trademark name or username is being used on any of 530+ new and popular social networks. Be the first to reserve your name and get help stopping others from using it - all in one place!